Comparative Interactions of Anesthetic Alkylphenols with Lipid Membranes

DOI: 10.4236/ojanes.2014.412044   PDF   HTML   XML   2,583 Downloads   3,019 Views   Citations


Objective: While substituted phenols have a variety of pharmacological activity, the mechanism underlying their anesthetic effects remains uncertain especially about the critical target. We characterized the lipid membrane-interacting properties of different phenols by comparing with general anesthetic propofol and local anesthetics. Based on the results, we also studied the pharmacological effects possibly associated with their membrane interactivities. Methods: 1,6-Diphenyl-1,3,5-hexatriene-labeled lipid bilayer membranes were prepared with 1,2-dipalmitoyl-phosphatidylcholine as model membranes and with different phospholipids and cholesterol to mimic neuronal membranes. These membrane preparations were treated with phenols and anesthetics at 1 - 200 μM, followed by measuring the fluorescence polarization to determine the membrane interactivities to change membrane fluidity. Antioxidant effects were fluorometrically determined using diphenyl-1-pyrenylphosphine-incorporated liposomes which were treated with 10 - 100 μM phenols, and then peroxidized with 10 μM peroxynitrite. Results: Several phenols interacted with the model membranes and the neuronal mimetic membranes to increase their fluidity at 1 - 10 μM as well as lidocaine and bupivacaine did at 50 - 200 μM. Their comparative potencies were propofol > thymol > isothymol > guaiacol > phenol > eugenol, and bupivacaine > lidocaine, consistent with the rank order of neuro-activity. These phenols inhibited membrane lipid peroxidation at 10 and 100 μM with the potencies correlating to their membrane interactivities. Conclusion: The structure-specific membrane interaction is at least in part responsible for the pharmacology of anesthetic alkylphenols. Membrane-interacting antioxidant alkylphenols may be protective against the peroxynitrite-relating ischemia/reperfusion injury.

Share and Cite:

Tsuchiya, H. and Mizogami, M. (2014) Comparative Interactions of Anesthetic Alkylphenols with Lipid Membranes. Open Journal of Anesthesiology, 4, 308-317. doi: 10.4236/ojanes.2014.412044.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Guenette, S.A., Beaudry, F., Marier, J.F. and Vachon, P. (2006) Pharmacokinetics and Anesthetic Activity of Eugenol in Male Sprague-Dawley Rats. Journal of Veterinary Pharmacology and Therapeutics, 29, 265-270.
[2] Park, S.H., Sim, Y.B., Lee, J.K., Kim, S.M., Kang, Y.J., Jung, J.S. and Suh, H.W. (2011) The Analgesic Effects and Mechanisms of Orally Administered Eugenol. Archives of Pharmacal Research, 34, 501-507.
[3] Mohammadi, B., Haeseler, G., Leuwer, M., Dengler, R., Krampfl, K. and Bufler, J. (2001) Structural Requirements of Phenol Derivatives for Direct Activation of Chloride Currents via GABAA Receptors. European Journal of Pharmacology, 421, 85-91.
[4] García, D.A., Bujons, J., Vale, C. and Suñol, C. (2006) Allosteric Positive Interaction of Thymol with the GABAA Receptor in Primary Cultures of Mouse Cortical Neurons. Neuropharmacology, 50, 25-35.
[5] Haeseler, G. and Leuwer, M. (2002) Interaction of Phenol Derivatives with Ion Channels. European Journal of Anaesthesiology, 19, 1-8.
[6] Kozek-Langenecker, S.A. (2002) The Effects of Drugs Used in Anaesthesia on Platelet Membrane Receptors and on Platelet Function. Current Drug Targets, 3, 247-258.
[7] Pramod, K., Ansari, S.H. and Ali, J. (2010) Eugenol: A Natural Compounds with Versatile Pharmacological Actions. Natural Product Communications, 5, 1999-2006.
[8] Riella, K.R., Marinho, R.R., Santos, J.S., Pereira-Filho, R.N., Cardoso, J.C., Albuquerque-Junior, R.L. and Thomazzi, S.M. (2012) Anti-Inflammatory and Cicatrizing Activities of Thymol, a Monoterpene of the Essential Oil from Lippia gracilis, in Rodents. Journal of Ethnopharmacology, 143, 656-663.
[9] Bocchinfuso, G., Bobone, S., Mazzuca, C., Palleschi, A. and Stella, L. (2011) Fluorescence Spectroscopy and Molecular Dynamics Simulations in Studies on the Mechanism of Membrane Destabilization by Antimicrobial Peptides. Cellular and Molecular Life Sciences, 68, 2281-2301.
[10] Lichtenberger, L.M., Zhou, Y., Jayaraman, V., Doyen, J.R., O’Neil, R.G., Dial, E.J., Volk, D.E., Gorenstein, D.G., Boggara, M.B. and Krishnamoorti, R. (2012) Insight into NSAID-Induced Membrane Alterations, Pathogenesis and Therapeutics: Characterization of Interaction of NSAIDs with Phosphatidylcholine. Biochimica et Biophysica Acta, 1821, 994-1002.
[11] Sheu, J.R., Hsiao, G., Luk, H.N., Chen, Y.W., Chen, T.L., Lee, L.W., Lin, C.H. and Chou, D.S. (2002) Mechanisms Involved in the Antiplatelet Activity of Midazolam in Human Platelets. Anesthesiology, 96, 651-658.
[12] Kazanci, N. and Severcan, F. (2007) Concentration Dependent Different Action of Tamoxifen on Membrane Fluidity. Bioscience Reports, 27, 247-255.
[13] Tsuchiya, H. (2010) Structure-Dependent Membrane Interaction of Flavonoids Associated with Their Bioactivity. Food Chemistry, 120, 1089-1096.
[14] Kopec, W., Telenius, J. and Khandelia, H. (2013) Molecular Dynamics Simulations of the Interactions of Medicinal Plant Extracts and Drugs with Lipid Bilayer Membranes. FEBS Journal, 280, 2785-2805.
[15] Sugimoto, M., Uchida, I., Fukami, S., Takenoshita, M., Mashimo, T. and Yoshiya, I. (2000) The α and γ Subunit-Dependent Effects of Local Anesthetics on Recombinant GABAA Receptors. European Journal of Pharmacology, 401, 329-337.
[16] Haeseler, G., Maue, D., Grosskreutz, J., Bufler, J., Nentwig, B., Piepenbrock, S., Dengler, R. and Leuwer, M. (2002) Voltage-Dependent Block of Neuronal and Skeletal Muscle Sodium Channels by Thymol and Menthol. European Journal of Anaesthesiology, 19, 571-579.
[17] Park, C.K., Kim, K., Jung, S.J., Kim, M.J., Ahn, D.K., Hong, S.D., Kim, J.S. and Oh, S.B. (2009) Molecular Mechanism for Local Anesthetic Action of Eugenol in the Rat Trigeminal System. Pain, 144, 84-94.
[18] Lundbæk, J.A. (2006) Regulation of Membrane Protein Function by Lipid Bilayer Elasticity: A Single Molecule Technology to Measure the Bilayer Properties Experienced by an Embedded Protein. Journal of Physics: Condensed Matter, 18, S1305-S1344.
[19] Søgaard, R., Werge, T.M., Bertelsen, C., Lundbye, C., Madsen, K.L., Nielsen, C.H. and Lundbæk, J.A. (2006) GABAA Receptor Function Is Regulated by Lipid Bilayer Elasticity. Biochemistry, 45, 13118-13129.
[20] Tsuchiya, H. and Mizogami, M. (2013) Characteristic Interactivity of Landiolol, an Ultra-Short-Acting Highly Selective β1-Blocker, with Biomimetic Membranes: Comparisons with β1-Selective Esmolol and Non-Selective Propranolol and Alprenolol. Frontiers in Pharmacology, 4, 150.
[21] Tsuchiya, H., Ueno, T., Tanaka, T., Matsuura, N. and Mizogami, M. (2010) Comparative Study on Determination of Antioxidant and Membrane Activities of Propofol and Its Related Compounds. European Journal of Pharmaceutical Sciences, 39, 97-102.
[22] Hendrich, A.B., Malon, R., Pola, A., Shirataki, Y., Motohashi, N. and Michalak, K. (2002) Differential Interaction of Sophora Isoflavonoids with Lipid Bilayers. European Journal of Pharmaceutical Sciences, 16, 201-208.
[23] Mainali, L., Feix, J.B., Hyde, J.S. and Subczynski, W.K. (2011) Membrane Fluidity Profiles as Deduced by Saturation-Recovery EPR Measurements of Spin-Lattice Relaxation Times of Spin Labels. Journal of Magnetic Resonance, 212, 418-425.
[24] Popitz-Bergez, F.A., Leeson, S., Strichartz, G.R. and Thalhammer, J.G. (1995) Relation between Functional Deficit and Intraneural Local Anesthetic during Peripheral Nerve Block. A Study in the Rat Sciatic Nerve. Anesthesiology, 83, 583-592.
[25] Huang, J.H., Thalhammer, J.G., Raymond, S.A. and Strichartz, G.R. (1997) Susceptibility to Lidocaine of Impulses in Different Somatosensory Afferent Fibers of Rat Sciatic Nerve. Journal of Pharmacology and Experimental Therapeutics, 282, 802-811.
[26] Sinnott, C.J., Cogswell 3rd, L.P., Johnson, A. and Strichartz, G.R. (2003) On the Mechanism by Which Epinephrine Potentiates Lidocaine’s Peripheral Nerve Block. Anesthesiology, 98, 181-188.
[27] Marín, L.D., Sánchez-Borzone, M. and García, D.A. (2011) Comparative Antioxidant Properties of Some Gabaergic Phenols and Related Compounds, Determined for Homogeneous and Membrane Systems. Medicinal Chemistry, 7, 317-324.
[28] Tsuchiya, H. (2001) Structure-Specific Membrane-Fluidizing Effect of Propofol. Clinical and Experimental Pharmacology and Physiology, 28, 292-299.
[29] Hikiji, W., Kudo, K., Usumoto, Y., Tsuji, A. and Ikeda, N. (2010) A Simple and Sensitive Method for the Determination of Propofol in Human Solid Tissues by Gas Chromatography-Mass Spectrometry. Journal of Analytical Toxicology, 34, 389-393.
[30] Bahri, M.A., Seret, A., Hans, P., Piette, J., Deby-Dupont, G. and Hoebeke, M. (2007) Does Propofol Alter Membrane Fluidity at Clinically Relevant Concentrations? An ESR Spin Label Study. Biophysical Chemistry, 129, 82-91.
[31] Sánchez, M.E., Turina, A.V., Garcia, D.A., Nolan, M.V. and Perillo, M.A. (2004) Surface Activity of Thymol: Implications for an Eventual Pharmacological Activity. Colloids and Surfaces B: Biointerfaces, 34, 77-86.
[32] Reiner, G.N., Fraceto, L.F., de Paula, E., Perillo, M.A. and García, D.A. (2013) Effects of Gabaergic Phenols on Phospholipid Bilayers as Evaluated by 1H-NMR. Journal of Biomaterials and Nanotechnology, 4, 28-34.
[33] Hume, W.R. (1984) An Analysis of the Release and the Diffusion through Dentin of Eugenol from Zinc Oxide-Eugenol Mixtures. Journal of Dental Research, 63, 881-884.
[34] Hashimoto, S., Uchiyama, K., Maeda, M., Ishitsuka, K., Furumoto, K. and Nakamura, Y. (1988) In Vivo and in Vitro Effects of Zinc Oxide-Eugenol (ZOE) on Biosynthesis of Cyclooxygenase Products in Rat Dental Pulp. Journal of Dental Research, 67, 1092-1096.
[35] Markowitz, K., Moynihan, M., Liu, M. and Kim, S. (1992) Biologic Properties of Eugenol and Zinc Oxide-Eugenol: A Clinically Oriented Review. Oral Surgery, Oral Medicine, Oral Pathology, 73, 729-737.
[36] Ross, S. and Foëx, P. (1999) Protective Effects of Anaesthetics in Reversible and Irreversible Ischaemia-Reperfusion Injury. British Journal of Anaesthesia, 82, 622-632.
[37] Lalu, M.M., Wang, W. and Schulz, R. (2002) Peroxynitrite in Myocardial Ischemia-Reperfusion Injury. Heart Failure Reviews, 7, 359-369.
[38] Radi, R. (2013) Peroxynitrite, a Stealthy Biological Oxidant. Journal of Biological Chemistry, 288, 26464-26472.
[39] Suzuki, Y.J., Tsuchiya, M., Wassall, S.R., Choo, Y.M., Govil, G., Kagan, V.E. and Packer, L. (1993) Structural and Dynamic Membrane Properties of α-Tocopherol and α-Tocotrienol: Implication to the Molecular Mechanism of Their Antioxidant Potency. Biochemistry, 32, 10692-10699.
[40] Lúcio, M., Ferreira, H., Lima, J.L. and Reis, S. (2007) Use of Liposomes to Evaluate the Role of Membrane Interactions on Antioxidant Activity. Analytica Chimica Acta, 597, 163-170.
[41] Gutiérrez, M.E., García, A.F., Africa de Madariaga, M., Sagrista, M.L., Casadó, F.J. and Mora, M. (2003) Interaction of Tocopherols and Phenolic Compounds with Membrane Lipid Components: Evaluation of Their Antioxidant Activity in a Liposomal Model System. Life Sciences, 72, 2337-2360.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.